業績

{ 80件 }

Tsuzuki A, Fujioka Y, Yoshida A, Kashiwagi S, Amano M, Hira T, Nakamura A, Miyoshi H, Atsumi T, Ohba Y.

Direct visualization of GLP-1 secretion by fluorescent fusion proteins.

J Diabetes Invest. 2022, in press

IF 4.232

  • 2022
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Cho KY, Miyoshi H, Nakamura A, Greenberg AS, Atsumi T.

Lipid droplet protein PLIN1 regulates inflammatory polarity in human macrophages and is involved in atherosclerotic plaque development by promoting stable lipid storage.

J Atheroscler Thromb, in press

IF: 4.928

  • 2022
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Nakamura A.

Glucokinase as a therapeutic target based on findings from the analysis of mouse models.

Endocr J, in press

IF: 2.349

  • 2022
  • 糖尿病・内分泌グループ
  • 欧文論文/総説

公益財団法人 福田記念医療技術振興財団 論文等表彰事業 優秀賞 亀田 玲奈先生

  • 2022
  • 糖尿病・内分泌グループ
  • 受賞

Shibayama Y, Alkhoury C, Nemazanyy I, Henneman N, Cagnard N, Girard M, Atsumi T, Panasyuk G.

Class 3 Phosphatidyl Inositol-3 Kinase Promotes Hepatic Glucocorticoid Receptor Stability and Transcriptional Activity Acta Physiologica, in press

IF: 6.311

  • 2022
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Yuki Oe, Hiroshi Nomoto, Akinobu Nakamura, Saki Kuwabara, Yuka Takahashi, Ayano Yasui, Rimi Izumihara, Aika Miya, Hiraku Kameda, Kyu Yong Cho, Tatsuya Atsumi, Hideaki Miyoshi Switching from insulin degludec plus dipeptidyl peptidase-4 inhibitor to insulin degludec/liraglutide improves glycemic variability in patients with type 2 diabetes: a preliminary prospective observation study J Diabetes Res, in press.

IF: 4.011

  • 2022
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Takahashi Y, Kameda H, Miya A, Nomoto H, Nakamura A, Nishimura H, Kimura H, Suzuki M, Konno S, Shimizu A, Matsuno Y, Okamoto M, Motegi H, Iwata N, Fujisawa H, Suzuki A, Sugimura Y, Miyoshi H, A tsumi T.

Lymphocytic panhypophysitis and anti-rabphilin-3A antibody with pulmonary sarcoidosis.

Pituitary, in press.

IF: 4.107

  • 2022
  • 糖尿病・内分泌グループ
  • 欧文論文/症例報告

Oe Y, Kameda H, Nomoto H, Sakamoto K, Soyama T, Cho KY, Nakamura A, Iwasaki K, Abo D, Kudo K, Miyoshi H, Atsumi T.

Favorable effects of burosumab on tumor-induced osteomalacia caused by an undetectable tumor: a case report Medicine, in press

IF: 1.889

  • 2021
  • 糖尿病・内分泌グループ
  • 欧文論文/症例報告

47回日本神経内分泌学会 若手研究奨励賞 関崎 知紀先生

  • 2021
  • 糖尿病・内分泌グループ
  • 受賞

Kamoshima H, Nomoto H, Yamashita K, Takahashi Y, Tsuchida K, Kuwabara S, Miya A, Cho KY, Kameda H, Nakamura A, Atsumi T, Taneda S, Kurihara Y, Aoki S, Ono Y, Miyoshi H.

Do the benefits of sodium-glucose cotransporter 2 inhibitors exceed the risks in patients with type 1 diabetes?

Endocrine Journal, in press.

IF: 2.349

  • 2021
  • 糖尿病・内分泌グループ
  • 欧文論文/原著